Gene · 2864
Papers1,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| GPCRs involved in metabolic diseases: pharmacotherapeutic development updates. | Acta Pharmacol Sin | 2024 | 38326623 | PubTator, text mining | PubMed |
| The role of free fatty acid receptor-1 in gastric contractions in Suncus murinus. | Food Funct | 2024 | 38318756 | PubTator, text mining | PubMed |
| 5,6-diHETE lactone (EPA-L) mediates hypertensive microvascular dilation by activating the endothelial GPR-PLC-IP3 signaling pathway. | Biochem Biophys Res Commun | 2024 | 38290177 | PubTator, text mining | PubMed |
| Effects of free fatty acid receptor (FFAR) signaling on the modulation of cancer cell functions under hypoxic conditions. | Biochem Biophys Res Commun | 2024 | 38280308 | PubTator, text mining | PubMed |
| Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion. | Int J Mol Sci | 2024 | 38256160 | PubTator, text mining | PubMed |
| Novel Therapeutic Agents for Management of Diabetes Mellitus: A Hope for Drug Designing against Diabetes Mellitus. | Life (Basel) | 2024 | 38255714 | PubTator, text mining | PubMed |
| Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes. | Biomedicines | 2024 | 38255279 | PubTator, text mining | PubMed |
| Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases. | Biomedicines | 2024 | 38255229 | PubTator, text mining | PubMed |
| FFAR4 activation inhibits lung adenocarcinoma via blocking respiratory chain complex assembly associated mitochondrial metabolism. | Cell Mol Biol Lett | 2024 | 38243188 | PubTator, text mining | PubMed |
| Palmitoleic acid protects microglia from palmitate-induced neurotoxicity in vitro. | PLoS One | 2024 | 38241239 | PubTator, text mining | PubMed |
| Evidence for cytochrome P450 3A4-mediated metabolic activation of SCO-267. | Biopharm Drug Dispos | 2024 | 38236698 | PubTator, text mining | PubMed |
| Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer. | BMC Cancer | 2024 | 38221626 | PubTator, text mining | PubMed |
| Structural basis for the ligand recognition and signaling of free fatty acid receptors. | Sci Adv | 2024 | 38198545 | PubTator, text mining | PubMed |
| Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists. | J Med Chem | 2024 | 38146625 | PubTator, text mining | PubMed |
| Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships. | Eur J Med Chem | 2024 | 38039791 | PubTator, text mining | PubMed |
| Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance. | Mol Metab | 2024 | 38036170 | PubTator, text mining | PubMed |
| Thiazolidinedione as a Promising Medicinal Scaffold for the Treatment of Type 2 Diabetes. | Curr Diabetes Rev | 2024 | 37867272 | PubTator, text mining | PubMed |
| A free fatty acid receptor agonist inducing autophagy in HT-29 cells by downregulating the AKT/mTOR signaling pathway. | J Cancer Res Ther | 2023 | 38376299 | PubTator, text mining | PubMed |
| The Na/K-ATPase role as a signal transducer in lung inflammation. | Front Immunol | 2023 | 38299144 | PubTator, text mining | PubMed |
| Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 Selectivity. | Mar Drugs | 2023 | 38248654 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2864/papers?page=5